How Analysts Feel About Balchem Corporation (NASDAQ:BCPC) After Decrease in Sellers?

March 19, 2018 - By Vivian Currie

 How Analysts Feel About Balchem Corporation (NASDAQ:BCPC) After Decrease in Sellers?

Investors sentiment increased to 1.58 in Q3 2017. Its up 0.44, from 1.14 in 2017Q2. It is positive, as 16 investors sold Balchem Corporation shares while 39 reduced holdings. 18 funds opened positions while 69 raised stakes. 27.53 million shares or 3.97% more from 26.48 million shares in 2017Q2 were reported.
46,746 were accumulated by Raymond James Fin Svcs Advsrs Inc. Moreover, Eagle Asset Mgmt has 0.1% invested in Balchem Corporation (NASDAQ:BCPC). Ny State Common Retirement Fund reported 529,560 shares stake. Price T Rowe Assocs Md has 0% invested in Balchem Corporation (NASDAQ:BCPC). Massachusetts-based Loring Wolcott And Coolidge Fiduciary Limited Liability Partnership Ma has invested 0.03% in Balchem Corporation (NASDAQ:BCPC). Martin Communications Inc Tn has invested 0.28% in Balchem Corporation (NASDAQ:BCPC). Citigroup, a New York-based fund reported 5,262 shares. Bankshares Of America Corp De invested in 289,889 shares. Clearbridge Lc has 0.33% invested in Balchem Corporation (NASDAQ:BCPC). Natixis reported 4,476 shares. Rocky Mountain Advisers Limited accumulated 0.01% or 20 shares. Alliancebernstein Limited Partnership has invested 0% of its portfolio in Balchem Corporation (NASDAQ:BCPC). Cambridge Inv Advsrs Inc reported 3,410 shares. Aviance Capital Lc, Florida-based fund reported 107 shares. Northern Corp holds 0.01% or 455,312 shares.

The stock of Balchem Corporation (NASDAQ:BCPC) registered a decrease of 7.72% in short interest. BCPC’s total short interest was 702,900 shares in March as published by FINRA. Its down 7.72% from 761,700 shares, reported previously. With 93,700 shares average volume, it will take short sellers 8 days to cover their BCPC’s short positions. The short interest to Balchem Corporation’s float is 2.22%.

The stock decreased 0.55% or $0.45 during the last trading session, reaching $81.62. About 13,608 shares traded. Balchem Corporation (NASDAQ:BCPC) has risen 37.77% since March 19, 2017 and is uptrending. It has outperformed by 21.07% the S&P500.

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries in the United States and internationally. The company has market cap of $2.62 billion. The companyÂ’s Human Nutrition & Health segment offers creamer systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, chocolate systems, ice cream bases and variegates, cereals, grain based snacks, and cereal based ingredients; microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. It has a 29.25 P/E ratio. The Company’s Animal Nutrition & Health segment provides microencapsulated products that enhance health and milk production in ruminant animals; chelation technology, which provides enhanced nutrient absorption for species; and choline chloride, an essential nutrient for monogastric animal health.

Balchem Corporation (NASDAQ:BCPC) Ratings Coverage

Among 2 analysts covering Balchem (NASDAQ:BCPC), 0 have Buy rating, 1 Sell and 1 Hold. Therefore 0 are positive. Balchem has $60 highest and $6000 lowest target. $60’s average target is -26.49% below currents $81.62 stock price. Balchem had 3 analyst reports since March 8, 2016 according to SRatingsIntel. Pivotal Research downgraded Balchem Corporation (NASDAQ:BCPC) on Friday, November 4 to “Sell” rating. The firm earned “Sell” rating on Friday, August 4 by Pivotal Research. The stock of Balchem Corporation (NASDAQ:BCPC) has “Neutral” rating given on Tuesday, March 8 by Sidoti.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.